[Federal Register Volume 87, Number 26 (Tuesday, February 8, 2022)]
[Notices]
[Page 7196]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-02599]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of a meeting of the Board of Scientific 
Counselors, National Cancer Institute.
    A portion of the meeting will be held as a virtual meeting and is 
open to the public as indicated below. Individuals who plan to view the 
virtual meeting and need special assistance or other reasonable 
accommodations to view the meeting, should notify the Contact Person 
listed below in advance of the meeting. The open session will be 
videocast and can be accessed from the NIH Videocasting and Podcasting 
website (http://videocast.nih.gov/).
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in sections 552b(c)(6), Title 
5 U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the National 
Cancer Institute, including consideration of personnel qualifications 
and performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute.
    Date: March 7, 2022.
    Open: 11:00 a.m. to 11:30 a.m.
    Agenda: Remarks from the NCI Director.
    Closed: 11:40 a.m. to 3:40 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.

    Name of Committee: Board of Scientific Counselors, National 
Cancer Institute.
    Date: March 8, 2022.
    Closed: 11:00 a.m. to 2:45 p.m.
    Agenda: To review and evaluate personnel qualifications and 
performance, and competence of individual investigators.
    Place: National Cancer Institute, 9609 Medical Center Drive, 
Bethesda, MD 20892 (Virtual Meeting).
    Contact Person: Brian E. Wojcik, Ph.D., Senior Review 
Administrator, Institute Review Office, Office of the Director, 
National Cancer Institute, National Institutes of Health, 9609 
Medical Center Drive, Room 3W414, Rockville, MD 20850, 240-276-5660, 
[email protected].

    Any interested person may file written comments with the 
committee by forwarding the statement to the Contact Person listed 
on this notice. The statement should include the name, address, 
telephone number and when applicable, the business or professional 
affiliation of the interested person.
    Information is also available on the Institute's/Center's home 
page: https://deainfo.nci.nih.gov/advisory/bsc/index.htm, where an 
agenda and any additional information for the meeting will be posted 
when available.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: February 3, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02599 Filed 2-7-22; 8:45 am]
BILLING CODE 4140-01-P